Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC)
Status:
Unknown status
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine the response rate, tolerance and overall
survival in patients with stage III, IVa, IVb NPC treated with neoadjuvant chemotherapy (TPF
regimen) and concurrent chemoradiation.
Secondary objectives of the study are to evaluate the distant metastases free survival, and
disease-free survival of patients with stage III,IVa, IVb NPC treated with this regimen.
The third objective of this study is to evaluate who may benifit from this treatment regimen.